Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Nanotechnology ; 21(6): 065103, 2010 Feb 10.
Article in English | MEDLINE | ID: mdl-20061598

ABSTRACT

Peptide amyloid aggregation is a hallmark of several human pathologies termed amyloid diseases. We have investigated the effect of electrostatically stabilized magnetic nanoparticles of Fe(3)O(4) on the amyloid aggregation of lysozyme, as a prototypical amyloidogenic protein. Thioflavin T fluorescence assay and atomic force microscopy were used for monitoring the inhibiting and disassembly activity of magnetic nanoparticles of Fe(3)O(4). We have found that magnetic Fe(3)O(4) nanoparticles are able to interact with lysozyme amyloids in vitro leading to a reduction of the amyloid aggregates, thus promoting depolymerization; the studied nanoparticles also inhibit lysozyme amyloid aggregation. The ability to inhibit lysozyme amyloid formation and promote lysozyme amyloid disassembly exhibit concentration-dependent characteristics with IC50 = 0.65 mg ml(-1) and DC50 = 0.16 mg ml(-1) indicating that nanoparticles interfere with lysozyme aggregation already at stoichiometric concentrations. These features make Fe(3)O(4) nanoparticles of potential interest as therapeutic agents against amyloid diseases and their non-risk exploitation in nanomedicine and nanodiagnostics.


Subject(s)
Ferrosoferric Oxide/pharmacology , Muramidase/chemistry , Nanoparticles/chemistry , Amyloidosis/drug therapy , Animals , Chickens , Ferrosoferric Oxide/chemistry , Humans , Magnetics , Protein Conformation , Protein Folding , Solubility
2.
Eur Biophys J ; 37(7): 1261-70, 2008 Sep.
Article in English | MEDLINE | ID: mdl-18385993

ABSTRACT

We have screened a library of structurally distinct acridine derivatives (19 compounds) for their ability to inhibit lysozyme amyloid aggregation in vitro. Studied acridines were divided into three structurally different groups depending on the molecule planarity and type of the side chain-planar acridines, spiroacridines and tetrahydroacridines. Thioflavine T fluorescence assay and transmission electron microscopy were used for monitoring the inhibiting activity of acridines. We have found that both the structure of the acridine side chains and molecule planarity influence their antiamyloidogenic activity. The planar acridines inhibited lysozyme aggregation effectively. Spiroacridines and tetrahydroacridines had no significant effect on the prevention of lysozyme fibrillization, probably resulting from the presence of the heterocyclic 5-membered ring and non-planarity of molecule. Moreover, in the presence of some tetrahydroacridines the enhanced extent of aggregation was detected. We identified the most active acridine derivates from studied compound library characterized by low micromolar IC50 values, which indicate their possible application for therapeutic purpose.


Subject(s)
Acridines/chemistry , Acridines/pharmacology , Enzyme Inhibitors/chemistry , Enzyme Inhibitors/pharmacology , Muramidase/antagonists & inhibitors , Muramidase/metabolism , Amyloid/metabolism , Animals , Benzothiazoles , Dose-Response Relationship, Drug , Molecular Weight , Protein Binding/drug effects , Small Molecule Libraries/chemistry , Small Molecule Libraries/pharmacology , Thiazoles/metabolism , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...